H.Res. 1284 · 117th Congress
Of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House of Representatives relating to the negotiation of prices for prescription drugs under the Medicare prescription drug program.
- Stage
- Reported from committee
- Sponsor
- Cathy McMorris Rodgers
- Introduced
- 2022-07-26
- Latest action
- 2022-09-30 · Reported adversely by the Committee on Energy and Commerce. H. Rept. 117-534.
Summary
This resolution directs the Department of Health and Human Services (HHS) to furnish to the House of Representatives any external or internal communications of the White House regarding the implications of imposing certain penalties on drug manufacturers that do not comply with HHS price negotiations under the Medicare prescription drug benefit.